PEAT Act of 2026
Sponsored By: Representative Rulli, Michael A. [R-OH-6]
Introduced
Summary
Prevents reclassifying a biologic as a 'biological product' solely because it includes a clinically inactive protein. The bill would amend 42 U.S.C. 262(i)(1) to add a new subparagraph that bars treating a biologic as a biological product based only on a clinically inactive protein, preserve the existing definitional anchor, make a minor punctuation correction, and would not create new funding or change eligibility, benefits, enforcement, or program structures.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Biologic makers shielded from reclassification
This bill would stop regulators from treating some biologic medicines as "biological products" just because they contain a clinically inactive protein. It would do this by amending 42 U.S.C. 262(i)(1) to add that prohibition. The change would mainly affect companies that make or sell those biologics, and the text shows no new funding or effective date.
Sponsors & CoSponsors
Sponsor
Rulli, Michael A. [R-OH-6]
OH • R
Cosponsors
Rep. Harshbarger, Diana [R-TN-1]
TN • R
Sponsored 4/30/2026
Rep. Luttrell, Morgan [R-TX-8]
TX • R
Sponsored 5/13/2026
Rep. Babin, Brian [R-TX-36]
TX • R
Sponsored 5/14/2026
Rep. Kennedy, Mike [R-UT-3]
UT • R
Sponsored 5/15/2026
Rep. Carter, John R. [R-TX-31]
TX • R
Sponsored 6/2/2026
Rep. Hamadeh, Abraham J. [R-AZ-8]
AZ • R
Sponsored 6/8/2026
Rep. Weber, Randy K. Sr. [R-TX-14]
TX • R
Sponsored 6/23/2026
Rep. Nehls, Troy E. [R-TX-22]
TX • R
Sponsored 6/24/2026
Rep. McCaul, Michael T. [R-TX-10]
TX • R
Sponsored 6/29/2026
Rep. Carter, Earl L. "Buddy" [R-GA-1]
GA • R
Sponsored 7/16/2026
Rep. Khanna, Ro [D-CA-17]
CA • D
Sponsored 7/20/2026
Rep. Langworthy, Nicholas A. [R-NY-23]
NY • R
Sponsored 8/13/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov